Linkage disequilibrium mapping in isolated populations: the example of Finland revisited
- PMID: 9770501
- PMCID: PMC22846
- DOI: 10.1073/pnas.95.21.12416
Linkage disequilibrium mapping in isolated populations: the example of Finland revisited
Abstract
Linkage disequilibrium analysis can provide high resolution in the mapping of disease genes because it incorporates information on recombinations that have occurred during the entire period from the mutational event to the present. A circumstance particularly favorable for high-resolution mapping is when a single founding mutation segregates in an isolated population. We review here the population structure of Finland in which a small founder population some 100 generations ago has expanded into 5.1 million people today. Among the 30-odd autosomal recessive disorders that are more prevalent in Finland than elsewhere, several appear to have segregated for this entire period in the "panmictic" southern Finnish population. Linkage disequilibrium analysis has allowed precise mapping and determination of genetic distances at the 0.1-cM level in several of these disorders. Estimates of genetic distance have proven accurate, but previous calculations of the confidence intervals were too small because sampling variation was ignored. In the north and east of Finland the population can be viewed as having been "founded" only after 1500. Disease mutations that have undergone such a founding bottleneck only 20 or so generations ago exhibit linkage disequilibrium and haplotype sharing over long genetic distances (5-15 cM). These features have been successfully exploited in the mapping and cloning of many genes. We review the statistical issues of fine mapping by linkage disequilibrium and suggest that improved methodologies may be necessary to map diseases of complex etiology that may have arisen from multiple founding mutations.
Figures





Similar articles
-
Positional cloning of disease genes: advantages of genetic isolates.Hum Hered. 2000 Jan-Feb;50(1):66-75. doi: 10.1159/000022892. Hum Hered. 2000. PMID: 10545759
-
The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population.Am J Hum Genet. 1996 Mar;58(3):506-12. Am J Hum Genet. 1996. PMID: 8644710 Free PMC article.
-
Batten disease gene, CLN3: linkage disequilibrium mapping in the Finnish population, and analysis of European haplotypes.Am J Hum Genet. 1995 Mar;56(3):654-62. Am J Hum Genet. 1995. PMID: 7887419 Free PMC article.
-
Molecular genetics of the Finnish disease heritage.Hum Mol Genet. 1999;8(10):1913-23. doi: 10.1093/hmg/8.10.1913. Hum Mol Genet. 1999. PMID: 10469845 Review.
-
Disease gene mapping in isolated human populations: the example of Finland.J Med Genet. 1993 Oct;30(10):857-65. doi: 10.1136/jmg.30.10.857. J Med Genet. 1993. PMID: 8230163 Free PMC article. Review. No abstract available.
Cited by
-
2002 William Allen Award address. Introductory speech for Albert de la Chapelle.Am J Hum Genet. 2003 Feb;72(2):233-5. doi: 10.1086/346214. Am J Hum Genet. 2003. PMID: 12635648 Free PMC article. No abstract available.
-
Inferring linkage disequilibrium between a polymorphic marker locus and a trait locus in natural populations.Genetics. 2000 Sep;156(1):457-67. doi: 10.1093/genetics/156.1.457. Genetics. 2000. PMID: 10978308 Free PMC article.
-
Mutation history of the roma/gypsies.Am J Hum Genet. 2004 Oct;75(4):596-609. doi: 10.1086/424759. Epub 2004 Aug 20. Am J Hum Genet. 2004. PMID: 15322984 Free PMC article.
-
Modeling linkage disequilibrium between a polymorphic marker locus and a locus affecting complex dichotomous traits in natural populations.Genetics. 2001 Aug;158(4):1785-800. doi: 10.1093/genetics/158.4.1785. Genetics. 2001. PMID: 11514462 Free PMC article.
-
Cancer in Jews: introduction and overview.Fam Cancer. 2004;3(3-4):177-92. doi: 10.1007/s10689-004-9538-y. Fam Cancer. 2004. PMID: 15516840 Review.
References
-
- Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, et al. Nature (London) 1996;380:152–154. - PubMed
-
- Ramsay G. Nat Biotech. 1998;16:40–44. - PubMed
-
- Wang D G, Fan J-B, Siao C-J, Berno A, Young P, Sapolsky R, Ghandour G, Perkins N, Winchester E, Spencer J. Science. 1998;280:1077–1082. - PubMed
-
- Peterson A C, Rienzo A D, Lehesjoki A-E, de la Chapelle A, Slatkin M, Freimer N B. Hum Mol Genet. 1995;4:887–894. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical